FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Potassium Acetate Injection
Status: Currently in Shortage
»Date first posted: 06/10/2019
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition

Expand all

Exela Pharma Sciences, LLC (Revised 04/16/2024)

Company Contact Information:
828-758-5474

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, 3.93 g/20 mL (NDC 51754-2001-4)	Channel was shipped wk of 4/8/24	Awaiting additional API for 20mL batches. Product available in 200mEq/100mL vials, NDC 51754-2004-4, cartons of 25 vials	Demand increase for the drug

Hospira, Inc., a Pfizer Company (Revised 03/28/2024)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Potassium Acetate, Injection, 196.3 mg/1 mL (NDC 0409-3294-51)	Limited Availability	Limited Supply Available. Next Delivery: May 2024; Estimated Recovery: June 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay	Delay in shipping of the drug
Potassium Acetate, Injection, 3.93 g/20 mL (NDC 0409-8183-01)	Unavailable	Next Delivery: May 2024; Estimated Recovery: June 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay	Delay in shipping of the drug
Potassium Acetate, Injection, 196.3 mg/1 mL (NDC 0409-3294-25)	Unavailable	Next Delivery and Estimated Recovery: June 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay	Delay in shipping of the drug
Potassium Acetate, Injection, 3.93 g/20 mL (NDC 0409-8183-25)	Unavailable	Next Delivery: May 2024; Estimated Recovery: June 2024; Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay	Delay in shipping of the drug